← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 30, 2018Last known activity
Sep 30, 2019
Acquired by LabCorp on Feb 21, 2022
Timeline
2010s
- Jan 1, 2010
Personal Genome Diagnostics (PGDx)— Founded
2020s
- Feb 21, 2022
LabCorp— Acquired By
Drugs by trial phase (3 distinct, 2 trials)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT04093167CollaboratorPhase 2Sep 30, 2019
- NCT03461952CollaboratorPhase 2Sep 30, 2018
Details
- Founded
- Baltimore, MD, US Jan 1, 2010
- Last known activity
- Sep 30, 2019